- Conditions
- Ulcerative Colitis
- Interventions
- Hyperbaric oxygen, Sham Hyperbaric Air
- Procedure
- Lead sponsor
- Dartmouth-Hitchcock Medical Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 18 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2016
- U.S. locations
- 3
- States / cities
- Rochester, Minnesota • Lebanon, New Hampshire • Pittsburgh, Pennsylvania
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 185
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Ulcerative Colitis
- Interventions
- Placebo, PF-00547659 SC Injection
- Drug
- Lead sponsor
- Shire
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 357 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2016
- U.S. locations
- 99
- States / cities
- Scottsdale, Arizona • La Jolla, California • Orange, California + 49 more
- Conditions
- Ulcerative Colitis
- Interventions
- Etrasimod, Placebo
- Drug
- Lead sponsor
- Arena Pharmaceuticals
- Industry
- Eligibility
- 16 Years to 80 Years
- Enrollment
- 354 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2021
- U.S. locations
- 62
- States / cities
- Dothan, Alabama • Mobile, Alabama • Sun City, Arizona + 54 more
- Conditions
- Inflammatory Bowel Disease
- Interventions
- PF 06687234, [124I]IB PF 06687234
- Biological
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years to 75 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2022
- U.S. locations
- 1
- States / cities
- New Haven, Connecticut
- Conditions
- Ulcerative Colitis
- Interventions
- BT051 200 mg, BT051 800 mg, BT051 3200 mg, Matching Placebo
- Drug
- Lead sponsor
- Adiso Therapeutics
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 24 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2022
- U.S. locations
- 2
- States / cities
- Rialto, California • Kissimmee, Florida
- Conditions
- Ulcerative Colitis
- Interventions
- ABX464, Placebo
- Drug
- Lead sponsor
- Abivax S.A.
- Industry
- Eligibility
- 16 Years and older
- Enrollment
- 1,116 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2030
- U.S. locations
- 72
- States / cities
- Dothan, Alabama • Litchfield Park, Arizona • Sun City, Arizona + 58 more
- Conditions
- Moderate to Severe Ulcerative Colitis
- Interventions
- Induction- PF-06480605 50 mg SC Q4W, Induction- PF-06480605 150 mg SC Q4W, Induction- PF-06480605 450 mg SC Q4W, Induction- Placebo SC Q4W, Chronic- PF-06480605 50 mg SC Q4W, Chronic- PF-06480605 150 mg SC Q4W, Chronic- PF-06480605 450 mg SC Q4W
- Drug · Other
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 246 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2022
- U.S. locations
- 55
- States / cities
- Dothan, Alabama • Little Rock, Arkansas • Newport Beach, California + 20 more
- Conditions
- Colitis, Ulcerative
- Interventions
- Etrolizumab, Placebo
- Drug
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 359 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2020
- U.S. locations
- 33
- States / cities
- Orange, California • San Diego, California • San Francisco, California + 29 more
- Conditions
- Ulcerative Colitis
- Interventions
- Cobitolimod 250 mg, Cobitolimod 500 mg, Placebo
- Drug
- Lead sponsor
- InDex Pharmaceuticals
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 171 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2023
- U.S. locations
- 25
- States / cities
- Granada Hills, California • Mission Viejo, California • Rancho Cucamonga, California + 17 more
- Conditions
- Ulcerative Colitis
- Interventions
- PTG-100, Placebo
- Drug
- Lead sponsor
- Protagonist Therapeutics, Inc.
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 98 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2018
- U.S. locations
- 21
- States / cities
- Los Angeles, California • Colorado Springs, Colorado • Miami, Florida + 17 more
- Conditions
- Ulcerative Colitis
- Interventions
- Etrasimod
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 16 Years to 80 Years
- Enrollment
- 896 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2029
- U.S. locations
- 133
- States / cities
- Dothan, Alabama • Lake Elsinore, California • Lancaster, California + 44 more
- Conditions
- Ulcerative Colitis
- Interventions
- Ozanimod, Placebo
- Drug
- Lead sponsor
- Celgene
- Industry
- Eligibility
- 18 Years to 73 Years
- Enrollment
- 199 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2019
- U.S. locations
- 10
- States / cities
- Anaheim, California • La Jolla, California • Oceanside, California + 7 more
- Conditions
- Ulcerative Colitis (UC)
- Interventions
- Placebo, Upadacitinib
- Drug
- Lead sponsor
- AbbVie
- Industry
- Eligibility
- 16 Years to 75 Years
- Enrollment
- 522 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2021
- U.S. locations
- 114
- States / cities
- Mobile, Alabama • Sun City, Arizona • Tempe, Arizona + 90 more
- Conditions
- Ulcerative Colitis, Gastrointestinal Disease, Inflammatory Bowel Disease
- Interventions
- Daclizumab
- Drug
- Lead sponsor
- Facet Biotech
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 150 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2006
- U.S. locations
- 30
- States / cities
- Huntsville, Alabama • Anaheim, California • Los Angeles, California + 24 more
- Conditions
- Ulcerative Colitis, IBD
- Interventions
- Brazikumab, Placebo
- Drug
- Lead sponsor
- AstraZeneca
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 242 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2023
- U.S. locations
- 51
- States / cities
- Phoenix, Arizona • Tucson, Arizona • Little Rock, Arkansas + 42 more
- Conditions
- Colitis, Ulcerative
- Interventions
- Guselkumab Subcutaneous, Guselkumab Intravenous
- Drug
- Lead sponsor
- Janssen Research & Development, LLC
- Industry
- Eligibility
- 2 Years to 17 Years
- Enrollment
- 112 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2027
- U.S. locations
- 3
- States / cities
- Oakland, California • Indianapolis, Indiana • Lake Success, New York
- Conditions
- Ulcerative Colitis
- Interventions
- tofacitinib, Placebo
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 614 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2015
- U.S. locations
- 71
- States / cities
- Mobile, Alabama • La Jolla, California • Los Angeles, California + 29 more
- Conditions
- Ulcerative Colitis
- Interventions
- RPC1063
- Drug
- Lead sponsor
- Celgene
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 877 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2024
- U.S. locations
- 10
- States / cities
- Tucson, Arizona • Anaheim, California • Mission Hills, California + 7 more
- Conditions
- Colitis, Ulcerative
- Interventions
- Etrasimod
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 2 Years to 11 Years
- Enrollment
- 24 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2034
- U.S. locations
- 10
- States / cities
- Indianapolis, Indiana • New York, New York
- Conditions
- Ulcerative Colitis, Crohn's Disease
- Interventions
- UTTR1147A
- Drug
- Lead sponsor
- Genentech, Inc.
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 143 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2022
- U.S. locations
- 1
- States / cities
- Greenville, North Carolina
- Conditions
- Active Ulcerative Colitis
- Interventions
- BG9418 (Interferon beta-1a), Placebo
- Drug
- Lead sponsor
- Biogen
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 123 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2010
- U.S. locations
- 5
- States / cities
- Birmingham, Alabama • Lakewood, Colorado • Bristol, Connecticut + 2 more
- Conditions
- Colitis, Ulcerative
- Interventions
- Placebo, COLAL-PRED
- Drug
- Lead sponsor
- Prometheus Laboratories
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 190 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2009
- U.S. locations
- 89
- States / cities
- Birmingham, Alabama • Huntsville, Alabama • Montgomery, Alabama + 78 more
- Conditions
- Ulcerative Colitis
- Interventions
- ALTB-268
- Biological
- Lead sponsor
- AltruBio Inc.
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2028
- U.S. locations
- 23
- States / cities
- San Diego, California • Littleton, Colorado • Miami, Florida + 20 more
- Conditions
- Inflammatory Bowel Diseases
- Interventions
- SHINGRIX
- Biological
- Lead sponsor
- Boston Medical Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2024
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts